These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9144358)

  • 101. The impact of donor-specific antibodies on graft outcome in pediatric renal transplantation from deceased donors.
    Piątosa B; Kwiatkowska A; Rubik J; Jarmużek W; Kluge P; Grenda R
    Ann Transplant; 2011; 16(4):32-9. PubMed ID: 22210419
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Concordance with established tests and reproducibility of results obtained with a new single antigen chip array for HLA antibody detection (HISTO SPOT® HLA AB).
    Launhardt K; Lefevre V; Souplet V; Prantl L; Marget M; Hovoricova B; Wenda S; Olivier C
    J Immunol Methods; 2021 Apr; 491():112971. PubMed ID: 33549571
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Agreement among HLA antibody detection assays is higher in ever-pregnant donors and improved using a consensus cutoff.
    Carrick DM; Johnson B; Kleinman SH; Vorhaben R; Chance SC; Lee JH; Roback JD; Pandey S; Sun Y; Busch MP; Norris PJ;
    Transfusion; 2011 May; 51(5):1105-16. PubMed ID: 21087285
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Prozone rates in the solid-phase platelet crossmatch assay and correlation with class I HLA antibody levels.
    Juskewitch JE; Zuccarelli MD; Clymer KK; Wakefield LL; Kreuter JD; Gandhi MJ
    Transfusion; 2021 Nov; 61(11):3236-3246. PubMed ID: 34523730
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Report of the second international soluble HLA (sHLA) workshop. Phoenix, Arizona, October 2, 1993.
    Grumet FC; Buelow R; Grosse-Wilde H; Kubens B; Garovoy M; Pouletty P
    Hum Immunol; 1994 Jul; 40(3):153-65. PubMed ID: 7960956
    [No Abstract]   [Full Text] [Related]  

  • 106. Detection of HLA Antibodies in Organ Transplant Recipients - Triumphs and Challenges of the Solid Phase Bead Assay.
    Tait BD
    Front Immunol; 2016; 7():570. PubMed ID: 28018342
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Novel solid phase-based ELISA assays contribute to an improved detection of anti-HLA antibodies and to an increased reliability of pre- and post-transplant crossmatching.
    Schlaf G; Pollok-Kopp B; Manzke T; Schurat O; Altermann W
    NDT Plus; 2010 Dec; 3(6):527-38. PubMed ID: 25949460
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Prolonged immunosuppression preserves nonsensitization status after kidney transplant failure.
    Casey MJ; Wen X; Kayler LK; Aiyer R; Scornik JC; Meier-Kriesche HU
    Transplantation; 2014 Aug; 98(3):306-11. PubMed ID: 24717218
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Sensitive solid-phase detection of donor-specific antibodies as an aid highly relevant to improving allograft outcomes.
    Schlaf G; Pollok-Kopp B; Altermann WW
    Mol Diagn Ther; 2014 Apr; 18(2):185-201. PubMed ID: 24170304
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Maternal alloimmunization against the rare platelet-specific antigen HPA-9b (Max a) is an important cause of neonatal alloimmune thrombocytopenia.
    Peterson JA; Balthazor SM; Curtis BR; McFarland JG; Aster RH
    Transfusion; 2005 Sep; 45(9):1487-95. PubMed ID: 16131382
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Comparison of the established standard complement-dependent cytotoxicity and flow cytometric crossmatch assays with a novel ELISA-based HLA crossmatch procedure.
    Altermann WW; Seliger B; Sel S; Wendt D; Schlaf G
    Histol Histopathol; 2006 Oct; 21(10):1115-24. PubMed ID: 16835834
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Detection of HLA class I-specific antibodies by the QuikScreen enzyme-linked immunosorbent assay.
    Lucas DP; Paparounis ML; Myers L; Hart JM; Zachary AA
    Clin Diagn Lab Immunol; 1997 May; 4(3):252-7. PubMed ID: 9144358
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Detection of donor-specific anti-HLA class I and II antibodies using antibody monitoring system.
    Yang CW; Oh EJ; Lee SB; Moon IS; Kim DG; Choi BS; Park SC; Choi YJ; Park YJ; Han K
    Transplant Proc; 2006 Nov; 38(9):2803-6. PubMed ID: 17112834
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Detection of panel-reactive anti-HLA class I antibodies by enzyme-linked immunosorbent assay or lymphocytotoxicity. Results of a blinded, controlled multicenter study.
    Buelow R; Mercier I; Glanville L; Regan J; Ellingson L; Janda G; Claas F; Colombe B; Gelder F; Grosse-Wilde H
    Hum Immunol; 1995 Sep; 44(1):1-11. PubMed ID: 8522449
    [TBL] [Abstract][Full Text] [Related]  

  • 116. A comparison of enzyme-linked immunoabsorbent assays and flow cytometry techniques for the detection of HLA specific antibodies.
    Worthington JE; Robson AJ; Sheldon S; Langton A; Martin S
    Hum Immunol; 2001 Oct; 62(10):1178-84. PubMed ID: 11600227
    [TBL] [Abstract][Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.